U.S. cancer clinical trial participants have become more diverse in makeup, but certain groups remain underrepresented, a new study finds. It’s important to have a wide range of participants in clinical trials, to find out if treatments are safe and effective for people with different characteristics, according to the National Cancer Institute (NCI), which has… read on > read on >



















